Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Merck has also decided to end the favezelimab clinical development program
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The companies will work with investigators to share the results with the scientific community
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Subscribe To Our Newsletter & Stay Updated
